Diabetes Type 2

Understanding Type 2 Diabetes

The body’s cells rely on glucose — a form of sugar — for energy. Glucose is obtained from food and delivered to the cells through the bloodstream.
In type 2 diabetes, the body either cannot produce enough insulin or cannot use it effectively, resulting in chronically elevated blood glucose levels (hyperglycemia). This condition gradually affects vital organs such as the heart, blood vessels, nerves, eyes, and kidneys, and significantly increases the risk of premature death.

Under normal conditions, insulin produced by pancreatic beta cells regulates glucose levels. In type 2 diabetes, insulin sensitivity decreases, leading to glucose accumulation in the bloodstream.
While the disease most often appears after the age of 45, it is now increasingly observed in younger adults and even children, primarily due to obesity and physical inactivity.

Common signs of diabetes include:

• Excessive thirst and frequent urination

• Constant hunger and fatigue

• Blurred vision

• Slow-healing wounds or frequent infections

• Darkened patches of skin, particularly around the neck or armpits

How Stem Cell Therapy Supports Type 2 Diabetes Management

Currently, there is no definitive cure for diabetes. Standard treatments focus on maintaining stable glucose levels through diet, exercise, medication, or insulin therapy.
However, regenerative medicine has introduced a new frontier: stem cell therapy.

Stem cells can transform into a variety of cell types and release biologically active molecules that stimulate tissue repair and regeneration. Research since the 1990s has shown that mesenchymal stem cells (MSCs) and bone marrow-derived mononuclear cells (MNCs) can:

• Preserve pancreatic beta-cell function

• Reduce insulin requirements

• Promote tissue repair in diabetic ulcers

• Improve overall glucose metabolism

By restoring cellular balance and supporting regeneration, stem cell therapy may improve metabolic stability and delay diabetes progression.

Clinical Results and Observed Improvements

Patients who undergo MSC-based therapy often report and demonstrate:

• Lower fasting glucose levels

• Decreased insulin or oral medication requirements

• Improved C-peptide and HbA1c levels

• Better appetite and weight regulation

• Enhanced energy and overall well-being

In cases involving diabetic foot ulcers, stem cell therapy has been shown to:

• Accelerate wound healing and tissue regeneration

• Reduce ulcer depth and size

• Increase oxygenation and local blood flow

• Restore healthy skin integrity

These improvements collectively contribute to a better quality of life and may reduce long-term complications associated with diabetes.

How the Treatment Works

Stem cell therapy for diabetes typically follows several stages:

1. Cell Collection – Stem cells are obtained either from the patient (bone marrow, adipose tissue, or blood) or from ethically approved donor sources (umbilical cord or placenta).

2. Processing and Cultivation – The collected cells are carefully isolated and expanded in certified laboratories to achieve the required therapeutic dose.

3. Administration – The stem cells are introduced into the patient’s body, usually via intravenous infusion or local injection near affected tissues (e.g., for diabetic ulcers).

When donor-derived stem cells are used, the preparation phase can be completed within 24 hours, as preprocessed, cryopreserved cells are available for immediate use.

Sources of Stem Cells

For type 2 diabetes, mesenchymal stem cells can be derived from:

• The patient’s own bone marrow, adipose tissue, or oral mucosa

• Donor sources such as the umbilical cord or placenta

Each case is individually evaluated by a specialist to determine the most appropriate cell source and treatment plan, based on the patient’s health condition and lab results.

Safety and Patient Comfort

All procedures at Stem Cell in Turkey are carried out in sterile, hospital-grade environments under the supervision of licensed physicians.
Local or general anesthesia ensures patient comfort during the harvesting process, and any post-procedure discomfort is mild and temporary.

Stem cell infusions are minimally invasive and similar in process to a standard IV drip, typically lasting one to two hours. When targeting localized complications, injections are administered directly around the affected tissue to enhance cell delivery and effectiveness.

Post-Treatment Follow-Up

Patients are re-evaluated 3 and 6 months after therapy through physical examination and laboratory testing to assess outcomes and determine whether additional treatment cycles are beneficial.
Improvements in blood sugar control, wound healing, and overall energy levels are commonly observed during this follow-up period.

Safety and Clinical Standards

A key focus in stem cell therapy is ensuring safety and preventing cellular abnormalities. Clinical research confirms that mesenchymal stem cells do not undergo malignant transformation when cultivated under proper laboratory conditions.
At Stem Cell in Turkey, every stage — from cell sourcing to administration — is governed by strict international quality protocols. Treatments are well-tolerated, with rare cases of mild, transient side effects.

A Regenerative Path Toward Balance

Stem cell therapy for type 2 diabetes does not replace lifestyle management or medical supervision — but it provides a powerful adjunctive tool to improve metabolic balance, enhance healing, and reduce complications.

By utilizing the body’s natural regenerative mechanisms, Stem Cell in Turkey helps patients regain control of their glucose regulation, reduce medication dependency, and restore vitality.

For personalized consultation about your case, contact our medical team to learn more about your eligibility for stem cell therapy for diabetes.